CinCor Pharma, Inc.
CINC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,339,257 | $710,455 | $586,425 | $566,706 |
| - Cash | $292,557 | $127,620 | $164,602 | $136,606 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,046,700 | $582,835 | $421,824 | $430,100 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$19,707 | -$21,353 | -$13,704 | -$29,330 |
| % Margin | – | – | – | – |
| Net Income | -$19,711 | -$20,521 | -$19,638 | -$33,441 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.48 | -0.54 | -0.59 | -0.94 |
| % Growth | 11.1% | 8.5% | 37.2% | – |
| Operating Cash Flow | -$15,114 | -$19,554 | -$17,713 | -$11,026 |
| Capital Expenditures | -$63 | $0 | $0 | $0 |
| Free Cash Flow | -$15,178 | -$19,554 | -$17,713 | -$11,026 |